US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug Legalcategory· November 18, 2024 Teva Pharmaceutical Industries raised its 2024 revenue and earnings ...

Last year, we took bold steps to ensure our sites were addressing antimicrobial resistance (AMR) throughout the entire ...

Teva Pharmaceutical ( (TEVA)) has provided an ... platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making ...

The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

Teva Pharmaceutical Industries Ltd. (TEVA ... some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance ...

Teva Pharmaceutical, the world’s largest generic drugmaker, was fined $503 million by European antitrust regulators for delaying competition to a blockbuster multiple sclerosis medicine.

Oct. 31 (UPI) --The European Commission fined Teva Pharmaceuticals $503 million for delaying competition posed by rival generic drugmakers, the company's second major financial penalty this month.

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA-0.99%decrease; red down pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in immunology and immuno-oncology programs with Teva Pharmaceuticals. Immunology is ...

NORTHAMPTON, MA / ACCESSWIRE / November 18, 2024 / Teva Pharmaceuticals is proud to share that our Community Routes: Access to Mental Health Care U.S. access program, in partnership with Direct ...